A H Kleemans

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The introduction of cholinesterase inhibitors to improve the cognitive function and activities of daily living in patients with Alzheimer disease, raises the question whether these drugs also have the potential to improve the quality of life of these patients. In this article a model is presented to measure quality of life in patients with dementia, in(More)
Measuring demented patients' 'quality of life' is an important issue in the Netherlands. Due to diminished cognition and other characteristics of dementia, general instruments are not suitable. A conceptual model for quality of life in dementia should guide instrument choice. We used a recently developed model, in which 'well-being' is indicated as the(More)
  • 1